Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

Pharmacy minister breaks silence by responding to C+D letter

The new pharmacy minister has broken his silence towards the sector by responding to a C+D letter suggesting which areas he should prioritise.

In an open letter to the minister, published last week (June 28), C+D editor James Waldron welcomed David Mowat to his new role.

Mr Waldron also used the letter to set out three areas the minister should focus on: listening to the sector, backing the regulator’s “programme or work” on workplace pressures, and reassessing the planned cuts to funding in England.

You can read the full letter here.

Mr Mowat responded on Twitter this morning (August 1), thanking C+D “for the welcome”. He branded pharmacy “an important frontline service” and added that he is “looking forward to supporting the sector as it modernises”.


He followed up his tweet by telling C+D that he is "looking forward to working with the sector to understand more about the opportunities and challenges in this area".

Mr Mowat also pledged to "make sure that we make the most of pharmacists’ skills and provide the best possible service to the public”.

Last month, both Pharmacy Voice and the Pharmaceutical Services Negotiating Committee said they had asked Mr Mowat for a meeting to clarify plans to cut funding in England by £170 million in October.

What questions do you have for the new pharmacy minister?

Related Content

Topics

         
Pharmacist Manager
Barnsley
£30 per hour

Apply Now
Latest News & Analysis
See All
UsernamePublicRestriction

Register

CD008260

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel